Wordt geladen...
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
The presence of minimal residual disease (MRD) is widely recognized as a powerful predictor of therapeutic outcome in acute myeloid leukemia (AML), but methods of measurement and quantification of MRD in AML are not yet standardized in clinical practice. There is an urgent, unmet need for robust and...
Bewaard in:
| Gepubliceerd in: | J Mol Diagn |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Investigative Pathology
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500824/ https://ncbi.nlm.nih.gov/pubmed/28525762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.03.005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|